Failure of peritoneal lavage to prevent operative site infection and peritoneal tumor recurrence in pancreatic surgery.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 06 03 2023
accepted: 18 08 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: epublish

Résumé

Although intraoperative peritoneal lavage often is performed routinely with the aim of reducing peritoneal contamination, evidence of lavage benefit in elective pancreatic surgery is limited. We retrospectively classified patients who had undergone pancreatic surgery to groups given or not given peritoneal lavage, then comparing clinical results. This saline lavage was performed at the end of the operation. The primary endpoint was rate of surgical site infection. Frequency of peritoneal recurrence also was evaluated. Among all 104 patients in the study, incidence of infectious complications in the lavage group (n = 65) was significantly higher than in the non-lavage group (n = 39; 35% vs. 15%, P = 0.041), while incidences of postoperative complications overall and surgical site infection did not differ between lavage (80% and 26%) and non-lavage groups (67% and 10%, P = 0.162 and 0.076, respectively). Among 63 patients undergoing pancratoduodenectomy, frequencies of positive bacterial cultures of drainage fluids on postoperative days 1 and 3 were greater in the non-lavage group (P < 0.001 and P = 0.012), but surgical site infection was significantly more frequent in the lavage group (P = 0.043). Among patients with pancreatic and biliary cancers, lavage did not affect frequency of peritoneal recurrence. Intraoperative lavage did not prevent surgical site infection or peritoneal recurrence of pancreatobiliary cancer.

Sections du résumé

BACKGROUND BACKGROUND
Although intraoperative peritoneal lavage often is performed routinely with the aim of reducing peritoneal contamination, evidence of lavage benefit in elective pancreatic surgery is limited.
METHODS METHODS
We retrospectively classified patients who had undergone pancreatic surgery to groups given or not given peritoneal lavage, then comparing clinical results. This saline lavage was performed at the end of the operation. The primary endpoint was rate of surgical site infection. Frequency of peritoneal recurrence also was evaluated.
RESULTS RESULTS
Among all 104 patients in the study, incidence of infectious complications in the lavage group (n = 65) was significantly higher than in the non-lavage group (n = 39; 35% vs. 15%, P = 0.041), while incidences of postoperative complications overall and surgical site infection did not differ between lavage (80% and 26%) and non-lavage groups (67% and 10%, P = 0.162 and 0.076, respectively). Among 63 patients undergoing pancratoduodenectomy, frequencies of positive bacterial cultures of drainage fluids on postoperative days 1 and 3 were greater in the non-lavage group (P < 0.001 and P = 0.012), but surgical site infection was significantly more frequent in the lavage group (P = 0.043). Among patients with pancreatic and biliary cancers, lavage did not affect frequency of peritoneal recurrence.
CONCLUSION CONCLUSIONS
Intraoperative lavage did not prevent surgical site infection or peritoneal recurrence of pancreatobiliary cancer.

Identifiants

pubmed: 37624419
doi: 10.1007/s00423-023-03080-3
pii: 10.1007/s00423-023-03080-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

333

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Büchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z’graggen K (2003) Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138:1310–1315
doi: 10.1001/archsurg.138.12.1310 pubmed: 14662530
Kimura W, Miyata H, Gotoh M, Hirai I, Kenjo A, Kitagawa Y, Shimada M, Baba H, Tomita N, Nakagoe T, Sugihara K, Mori M (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259:773–780
doi: 10.1097/SLA.0000000000000263 pubmed: 24253151
Cameron JL, He J (2015) Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 220:530–536
doi: 10.1016/j.jamcollsurg.2014.12.031 pubmed: 25724606
Riviere D, Gurusamy KS, Kooby DA, Vollmer CM, Besselink MG, Davidson BR, van Laarhoven CJ (2016) Laparoscopic versus open distal pancreatectomy for pancreatic cancer. Cochrane Database Syst Rev 4:CD011391
pubmed: 27043078
Scholten L, Stoop TF, Del Chiaro M, Busch OR, van Eijck C, Molenaar IQ, de Vries JH, Besselink MG, Dutch Pancreatic Cancer Group (2019) Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg 106:1735–1746
doi: 10.1002/bjs.11296 pubmed: 31502658
Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210
doi: 10.1016/j.gassur.2006.08.018 pubmed: 17114007
Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ (2008) Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 207:490–498
doi: 10.1016/j.jamcollsurg.2008.05.003 pubmed: 18926450
Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF (2009) National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg 13:1798–1805
doi: 10.1007/s11605-009-0936-1 pubmed: 19506975
Okano K, Hirao T, UnnoM FT, Yoshitomi H, Suzuki S, Satoi S, Takahashi S, Kainuma O, Suzuki Y (2015) Postoperative infectious complications after pancreatic resection. Br J Surg 102:1551–1560
doi: 10.1002/bjs.9919 pubmed: 26387569
Joliat GR, Sauvain MO, Petermann D, Halkic N, Demartines N, Schäfe M (2018) Surgical site infections after pancreatic surgery in the era of enhanced recovery protocols. Medicine 97(31):e11728
doi: 10.1097/MD.0000000000011728 pubmed: 30075582 pmcid: 6081186
Whiteside OJH, Tytherleigh MG, Thrush S, Farouk R, Galland RG (2005) Intra-operative peritoneal lavage — who does it and why? Ann R Coll Surg Engl 87:255–258
doi: 10.1308/1478708051847 pubmed: 16053685 pmcid: 1963932
Burnett WE, Brown GR Jr, Rosemond GP, Caswell HT, Buchor RB, Tyson RR (1957) The treatment of peritonitis using peritoneal lavage. Ann Surg 145:675–682
doi: 10.1097/00000658-195705000-00009 pubmed: 13425276 pmcid: 1465723
Schein M, Gecelter G, Freinkel W, Gerding H, Becker PJ (1990) Peritoneal lavage in abdominal sepsis A controlled clinical study. Arch Surg 125:1132–1135
doi: 10.1001/archsurg.1990.01410210058008 pubmed: 2400306
Morimoto M, Taniguchi K, Yamamoto O, Naka T, Sugitani A, Fujiwara Y (2021) Evaluation of blood supply with indocyanine green fluorescence in resection for concurrent gastric and pancreatic cancer: a case report. Yonago Acta Med 64:133–136
doi: 10.33160/yam.2021.02.017 pubmed: 33642914 pmcid: 7902162
Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133:521–527
doi: 10.1067/msy.2003.146 pubmed: 12773980
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250–280
doi: 10.1086/501620 pubmed: 10219875
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591
doi: 10.1016/j.surg.2016.11.014 pubmed: 28040257
Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zasshi 85:1001–1005 (In Japanese with English abstract)
pubmed: 6438478
Hall JC, Heel KA, Papadamitriou J, Platell C (1998) The pathobiology of peritonitis. Gastroenterology 114:185–196
doi: 10.1016/S0016-5085(98)70646-8 pubmed: 9428232
Adam U, Ledwon D, Hopt UT (1997) Programmed lavage as a basic principle in therapy of diffuse peritonitis. Langenbecks Arch Chir 382:S18–S21
doi: 10.1007/PL00014638 pubmed: 9333702
Platell C, Papadimitriou JM, Hall JC (2000) The influence of lavage on peritonitis. J Am Coll Surg 191:672–680
doi: 10.1016/S1072-7515(00)00726-2 pubmed: 11129818
Tolhurst Cleaver CL, Hopkins AD, Kee Kwong KC, Raftery AT (1974) The effect of postoperative peritoneal lavage on survival, peritoneal wound healing and adhesion formation following fecal peritonitis: an experimental study in the rat. Br J Surg 61:601–604
doi: 10.1002/bjs.1800610804 pubmed: 4854774
Whitaker D, Papadimitriou JM, Walters MN (1982) The mesothelium and its reactions: a review. Crit Rev Toxicol 10:81–144
doi: 10.3109/10408448209041321 pubmed: 7044686
Yaacobi Y, Goldberg EP, Habal MB (1991) Effect of Ringer’s lactate irrigation on the formation of postoperative abdominal adhesions. J Invest Surg 4:31–36
doi: 10.3109/08941939109140759 pubmed: 1863585
Breborowicz A, Rodela H, Oreopoulos DG (1992) Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41:1280–1285
doi: 10.1038/ki.1992.190 pubmed: 1614042
Maddaus MA, Ahrenholz D, Simmons RL (1988) The biology of peritonitis and implications for treatment. Surg Clin North Am 68:431–443
doi: 10.1016/S0039-6109(16)44487-7 pubmed: 3279556
Lamperi S, Carozzi S (1988) Immunologic patterns in CAPD patients with peritonitis. Clin Nephrol 30:S41–S44
pubmed: 3052960
Dunn DL, Barke RA, Ahrenholz DH, Humphrey EW, Simmons RL (1984) The adjuvant effect of peritoneal fluid in experimental peritonitis Mechanism and clinical implications. Ann Surg 199:37–43
doi: 10.1097/00000658-198401000-00007 pubmed: 6362582 pmcid: 1353255
Minervini S, Bentley S, Youngs D, Alexander-Williams J, Burdon DW, Keighley MR (1980) Prophylactic saline peritoneal lavage in elective colorectal operations. Dis Colon Rectum 23:392–394
doi: 10.1007/BF02586785 pubmed: 7418576
van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129–137
doi: 10.1056/NEJMoa0903230 pubmed: 20071702
Morris-Stiff G, Tamijmarane A, Tan YM, Shapey I, Bhati C, Mayer AD, Buckels JA, Bramhall SR, Mirza DF (2011) Pre-operative stenting is associated with a higher prevalence of post-operative complications following pancreatoduodenectomy. Int J Surg 9:145–149
doi: 10.1016/j.ijsu.2010.10.008 pubmed: 21029795
Cortes A, Sauvanet A, Bert F, Janny S, Sockeel P, Kianmanesh R, Ponsot P, Ruszniewski P, Belghiti J (2006) Effect of bile contamination on immediate outcomes after pancreaticoduodenectomy for tumor. J Am Coll Surg 202:93–99
doi: 10.1016/j.jamcollsurg.2005.09.006 pubmed: 16377502
Tsuchida H, Fujii T, Mizuma M, Satoi S, Igarashi H, Eguchi H, Kuroki T, Shimizu Y, Tani M, Tanno S, Tsuji Y, Hirooka Y, Masamune A, Mizumoto K, Itoi T, Egawa S, Kodama Y, Hamada S, Unno M et al (2019) Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: a nationwide, cancer registry-based study from the Japan Pancreas Society. Surgery 166:997–1003
doi: 10.1016/j.surg.2019.06.023 pubmed: 31445763
Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H (2005) EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol 27:1321–1328
pubmed: 16211228
Saif A, Teke M, Ryan C, Papai E, Nevler A, Hernandez JM, Lavu H (2022) The WASH (Water or Saline at High Volumes) Trial: a randomized trial to assess the survival impact of extensive peritoneal lavage using distilled water or saline at high volumes after pancreatic resection for pancreatic ductal adenocarcinoma. Ann Surg Oncol 29:5372–5374
doi: 10.1245/s10434-022-11978-3 pubmed: 35661956

Auteurs

Mai Ishihara (M)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan.

Akihiro Nakamura (A)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan.

Yuki Takahashi (Y)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan.

Yuzo Minegishi (Y)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan.

Kenichi Matsuo (K)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan.

Kuniya Tanaka (K)

General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan. u1792ts235@med.showa-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH